Viemed Healthcare Inc

Viemed Healthcare Inc(VMD)股票分析

$9.800

-0.119 (-1.21%)收盤時

Loading chart…
最高
9.990
開盤
9.910
成交量加權均價
9.85
成交量
123.14K
市值
251.17M
最低
9.760
成交金額
1.21M
企業價值/稅息折舊攤銷前利潤(TTM)
7.12

Viemed Healthcare, Inc. is an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, including non-invasive ventilators (NIV), sleep therapy, staffing, and other complementary products and services. The Company focuses on in-home treatment with clinical practitioners providing therapy, education and counseling to patients in their homes using high-touch and high-tech services. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment solutions, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, oxygen concentrators, breast pumps for women, respiratory devices and other medical equipment. It offers in-home sleep apnea testing services. The Company also provides healthcare staffing and recruitment services.

AI 分析 of Viemed Healthcare Inc (VMD)

持有

Viemed Healthcare Inc (VMD) is currently a hold. The stock is priced at $9.48, with a forward P/E of 18.35, indicating potential for growth, but recent earnings missed expectations with an EPS of $0.07 compared to the estimate of $0.10. The company has shown strong revenue growth, with a 31.3% year-to-date change, but the recent downgrade by Freedom Broker suggests caution due to near-term profitability pressures.

估值指標

Viemed Healthcare Inc(VMD)目前預期本益比為 18.35,5 年平均預期本益比為 23.92。

預期本益比

合理
5 年均值 P/E
23.92
目前P/E
18.35
高估
30.93
低估
16.91

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
6.05
目前EV/EBITDA
7.12
高估
7.37
低估
4.72

預期股價營收比

合理
5 年均值 P/S
1.31
目前P/S
1.07
高估
1.65
低估
0.98

Alphio AI 對 VMD 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%VMD

$9.49

情境價格

基

基準

基準 · 50%VMD

$8.88

情境價格

悲

悲觀

悲觀 · 25%VMD

$7.16

情境價格

事件時間軸

2026-03-04 (ET)

16:50:00

Viemed Healthcare Authorizes Share Repurchase Program Through March 2027

2025-07-02 (ET)

08:43:56

Viemed Healthcare completes acquisition of Lehan's Medical Equipment

2025-06-09 (ET)

08:18:09

Viemed Healthcare board authorizes share repurchase program up to 5%

2025-05-06 (ET)

08:32:47

Viemed entered into definitive agreement to acquire Lehan's Medical Equipment

2025-03-10 (ET)

17:02:06

Viemed Healthcare sees FY25 revenue $254M-$265M, consensus $251.43M

資訊

VMD 常見問題 —— 由 Alphio AI 解答

Viemed Healthcare, Inc. is an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, including non-invasive ventilators (NIV), sleep therapy, staffing, and other complementary products and services. The Company focuses on in-home treatment with clinical practitioners providing therapy, education and counseling to patients in their homes using high-touch and high-tech services. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment solutions, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, oxygen concentrators, breast pumps for women, respiratory devices and other medical equipment. It offers in-home sleep apnea testing services. The Company also provides healthcare staffing and recruitment services. It operates in the Healthcare sector (SERVICES-MISC HEALTH & ALLIED SERVICES, NEC industry).

Viemed Healthcare Inc (VMD) is currently a hold. The stock is priced at $9.48, with a forward P/E of 18.35, indicating potential for growth, but recent earnings missed expectations with an EPS of $0.07 compared to the estimate of $0.10. The company has shown strong revenue growth, with a 31.3% year-to-date change, but the recent downgrade by Freedom Broker suggests caution due to near-term profitability pressures.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易